autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02903537)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- SphingomyelinImmunity, desensitized
Sphingomyelin immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02903537 | Phase 1 | Sep 1, 2016 | Badalona Hospital Germans Trias i Pujol, Clinica Universidad de Navarra |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Badalona Hospital Germans Trias i Pujol | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Clinica Universidad de Navarra | Academic/Hospital | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1